E. White (Ann Arbor, United States of America), M. Kolb (Hamilton, Canada)
LSC 2014 abstract - The role of the formyl peptide receptor in the development of pulmonary fibrosis
B. Millar, L. Murray, D. Finch, A. Carruthers, O. Ferguson, M. Sleeman, D. Mann, A. Fisher (Newcastle-upon-Tyne, Cambridge, United Kingdom)
|  |
Effects of extracellular vesicles from mesenchymal stromal cells in experimental silicosis
E. Bandeira, H. Oliveira, J. Silva, R. Mena-Barreto, P. Rocco, M. Morales (Rio de Janeiro, Brazil)
| |
Regulation of WISP1 by profibrotic cytokines in pulmonary fibrosis
S. Klee, V. Aumiller, B. Berschneider, M. Königshoff (Munich, Germany)
| |
LSC 2014 abstract - Deglycosylated bleomycin, while keeping bleomycin's antitumor activity, is devoid of its strong pulmonary toxicity
O. Burgy, G. Wettstein, P. S. Bellaye, D. Nathalie, A. Kenani, J. F. Hernandez, A. Bettaieb, P. Camus, C. Garrido, P. Bonniaud (Dijon, Montpellier, France; Monastir, Tunisia)
|  |
The role of 5-HT2 receptors in the early development of lung fibrosis
A. Löfdahl, M. C. Holst, L. Thiman, C. Wenglén, K. Rydell-Törmänen, A. K. Larsson Callerfelt, G. Ekström, G. Westergren-Thorsson (Lund, Sweden)
| |
Functional and molecular disparities between mesenchymal stem cells from various pulmonary disorders
C. Rio, A. Jahn, P. Marti, A. Iglesias, L. Fueyo, O. Gigirey, J. A. Torrecilla, A. Carvajal, C. Balaguer, A. Noguera, A. Peralta, L. Ortiz, E. Sala-Llinas (Palma de Mallorca, Spain; Pittsburgh, United States Of America)
|  |
Proteasome function in pulmonary fibrosis
N. Semren, M. Korfei, I. Fernandez, A. Günther, O. Eickelberg, S. Meiners (München, Giessen, Germany)
| |
LSC 2014 abstract - Influenza infection may cause exacerbation of lung fibrosis through collagen deposition
A. Stavrou, L. Jolly, N. Glanville, A. Habgood, J. Porte, A. Tatler, A. Blanchard, S. Johnston, G. Jenkins (Nottingham, London, Stevenage, United Kingdom)
| |